Juncture Wealth Strategies, Llc
Source: SEC Form 13F · as of Mar 2026Juncture Wealth Strategies, Llc holds 12 biotech & pharma companies tracked by BioSniper, totaling $7.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$7.0M
| Company | Shares | Value |
|---|---|---|
| CPRXCATALYST PHARMACEUTICALS, INC. | 71,809 | $1.8M |
| GMEDGlobus Medical Inc. | 9,526 | $821K |
| HALOHALOZYME THERAPEUTICS, INC. | 10,681 | $690K |
| GILDGILEAD SCIENCES, INC. | 4,539 | $633K |
| NBIXNEUROCRINE BIOSCIENCES INC | 4,543 | $598K |
| ETONEton Pharmaceuticals, Inc. | 19,181 | $473K |
| KNSAKiniksa Pharmaceuticals International, plc | 9,470 | $456K |
| ABBVAbbVie Inc. | 1,759 | $383K |
| PTCTPTC THERAPEUTICS, INC. | 5,148 | $351K |
| NVSNovartis AG | 2,283 | $349K |
| JNJJOHNSON & JOHNSON | 1,234 | $302K |
| AUPHAurinia Pharmaceuticals Inc. | 10,140 | $150K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.